Risankizumab demonstrates effectiveness in achieving steroid-free clinical remission in the real-world cohort of patients with refractory Crohn's disease, with a favourable safety profile. Medscape News UK Source link : https://www.medscape.com/viewarticle/real-world-data-show-efficacy-risankizumab-refractory-crohns-2026a1000kgx?src=rss...
Read more






